Leiding, J. W., Arnold, D. E., Parikh, S., Logan, B., Marsh, R. A., Griffith, L. M., Wu, R., Kidd, S., Mallhi, K., Chellapandian, D., Si Lim, S. J., Grunebaum, E., Falcone, E. L., Murguia-Favela, L., Grossman, D., Prasad, V. K., Heimall, J. R., Touzot, F., Burroughs, L. M., … Kang, E. M. (2023). Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD. Blood, 142(24), 2105–2118. https://doi.org/10.1182/blood.2022019586

LaBere, B., Gutierrez, M. J., Wright, H., Garabedian, E., Ochs, H. D., Fuleihan, R. L., Secord, E., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Notarangelo, L. D., & Chen, K. (2022). Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. The Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1325-1333.e5. https://doi.org/10.1016/j.jaip.2021.12.035